By Dean Seal

Shares of Waters Corp. rose after the company raised its full-year outlook on the back of big top- and bottom-line gains in the third quarter.

The stock was up 9.7% at $379.24 on Tuesday. Shares are back in positive territory year-to-date.

The maker of healthcare and science products said its pharmaceutical segment grew in the double-digit percentage range heading into the second year of an instrument replacement cycle. New liquid chromatography-mass spectrometry products and chemistry products are showing strength as well, Chief Executive Udit Batra said.

For the third quarter, Waters posted a profit of $148.9 million, or $2.50 a share, compared with $161.5 million, or $2.71 a share, in the same quarter a year earlier.

Stripping out one-time items, adjusted earnings were $3.40 a share. Analysts surveyed by FactSet had been expecting $3.21 a share.

Sales were up 8% at $799.9 million, topping analyst targets of $781 million, according to FactSet.

Waters now expects adjusted earnings of $13.05 to 13.15 a share for the year, up from a prior estimate for $12.95 to $13.05 a share. Sales should rise 6.5% to 7.1% instead of 5% to 7% as previously projected.

In the current quarter, adjusted earnings are on track to hit $4.45 to $4.55 a share, the company said. That's shy of the $4.58 a share analysts polled by FactSet had been forecasting.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

November 04, 2025 10:57 ET (15:57 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.